Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Children with atopic dermatitis often have sleep problems, affecting their growth and behavior.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

A new gene, JMJD1C, may affect testosterone levels in men.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

PRP and HF-MSCs treatment improves hair growth, thickness, and density in androgenetic alopecia.

Many people with alopecia experience high levels of social anxiety, anxiety, and depression, and while wigs can boost confidence, they may also cause anxiety.

Prostaglandin D2 blocks new hair growth after skin injury through the Gpr44 receptor.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

People with hair loss feel more depressed and anxious, especially women, and need help managing emotions and beliefs about their condition.

Latanoprost, a glaucoma drug, showed potential for promoting hair growth in bald monkeys, especially at higher doses.

Finasteride effectively treats hair loss in transgender men with few side effects.

Alopecia affects patients' quality of life, with younger patients and longer-lasting hair loss experiencing greater impact.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

Children with trichotillomania often pull hair from their scalp, and parents may not notice; stress can trigger it, and asking detailed questions helps in diagnosis and treatment.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

People with Lichen Planopilaris tend to be more depressed, have lower self-esteem, and a worse quality of life.